MediGene AG has entered into a collaboration with the Johns Hopkins University in Baltimore, US to test candidate vaccines against the human papillomaviruses using an adeno-associated virus platform. Financial terms were not disclosed. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
